Image credit: Kimimasa Mayama/EPA/Shutterstock
A Japanese flu drug gets upbeat reviews in China for blunting the impact of Covid-19 — and that is bolstering Gilead's case for remdesivir
We’re starting to get the first round of data on drugs being used to rein in the devastating outbreak of Covid-19 in China. And one …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
